Streetbeat News

Analyst Ratings

MATW

B. Riley Securities has maintained a Buy rating on Matthews International (NASDAQ:MATW) but has lowered the price target from $54 to $40.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 5:00 pm

META

In the past three months, 43 analysts have rated Meta Platforms (NASDAQ:META), with most being bullish. The average 12-month price target has increased by 7.55% to $591. Analysts have raised their price targets, reflecting positive sentiment towards Meta's financial performance, including strong revenue growth and profitability.

Portfolio Pulse from Benzinga Insights

September 26, 2024 | 5:00 pm

VRDN

BTIG analyst Julian Harrison maintains a Buy rating on Viridian Therapeutics and raises the price target from $56 to $61.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 5:00 pm

MIR

B. Riley Securities has initiated coverage on Mirion Technologies with a Buy rating and set a price target of $14.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 4:57 pm

SPOK

B. Riley Securities has initiated coverage on Spok Holdings with a Neutral rating and set a price target of $15.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 4:55 pm

EXAS

Raymond James analyst Andrew Cooper has reiterated a Market Perform rating on Exact Sciences (NASDAQ:EXAS).

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 4:55 pm

INFU

B. Riley Securities has initiated coverage on InfuSystems Holdings with a Buy rating and set a price target of $13.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 4:53 pm

TCMD

B. Riley Securities has initiated coverage on Tactile Systems Tech (NASDAQ:TCMD) with a Buy rating and set a price target of $23.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 4:51 pm

MU

Raymond James analyst Srini Pajjuri has maintained an 'Outperform' rating on Micron Technology and raised the price target from $125 to $140.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 4:47 pm

MD

Pediatrix Medical Group's stock is experiencing an upward trend following an upgrade by Jefferies from Hold to Buy, with a price target increase from $8 to $14.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 4:45 pm